by news source | Feb 20, 2019 | What's news
Researchers at the University of Geneva, Switzerland, modified human pancreatic cells with DNA to produce insulin and introduced these cells into diabetic mice, decreasing blood-sugar levels to normal—providing hope for human applications. Nature
